Predicting Marfan Syndrome in Children With Congenital Ectopia Lentis: Development and Validation of a Nomogram

Kityee Ng1, Bo Qu2, Qianzhong Cao1

  • 1State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China.

Insights

This study developed a nomogram to predict Marfan syndrome (MFS) in children with congenital ectopia lentis (CEL). The tool accurately identifies MFS, enabling early intervention and improved patient outcomes.

Area of Science:

  • Genetics and Ophthalmology
  • Pediatric Cardiology
  • Medical Diagnostics

Background:

  • Marfan syndrome (MFS) is a genetic disorder affecting connective tissue.
  • Congenital ectopia lentis (CEL) is a key indicator of potential MFS.
  • Accurate early diagnosis is crucial for managing MFS complications.

Purpose of the Study:

  • To develop a predictive nomogram for Marfan syndrome (MFS) in pediatric patients presenting with congenital ectopia lentis (CEL).
  • To utilize routinely collected clinical data for effective MFS prediction.
  • To create a tool for personalized risk assessment in children with CEL.

Main Methods:

  • Applied Ghent nosology and genetic testing to diagnose MFS in CEL patients.
  • Utilized logistic regression to build a prediction model based on identified MFS predictors.
  • Validated the nomogram's predictive performance using ROC curves, calibration plots, and decision curve analysis.

Main Results:

  • Identified key predictors: BMI Z-score, corneal curvature radius, and aortic root diameter.
  • The nomogram demonstrated strong predictive ability with an AUC of 0.889.
  • Calibration and decision curve analyses confirmed the nomogram's clinical utility and discriminatory power.

Conclusions:

  • The developed nomogram offers accurate, individualized prediction of MFS in children with CEL, especially those not meeting strict Ghent criteria.
  • This tool facilitates personalized treatment strategies and improved outcomes for MFS.
  • Early identification via the nomogram can mitigate severe symptoms and enhance patient prognosis.
Abstract